Qing Meng, PhD

Qing Meng

In July 2023, we changed our name from AACC (short for the American Association for Clinical Chemistry) to the Association for Diagnostics & Laboratory Medicine (ADLM). The following page was written prior to this rebranding and contains mentions of the association’s old name. It may contain other out-of-date information as well.

2021 AACC Award for Outstanding Contributions to Clinical Chemistry in a Selected Area of Research

Qing H. Meng, PhD, DABCC, FADLM is the section chief and professor of clinical chemistry in the Department of Laboratory Medicine at The University of Texas MD Anderson Cancer Center. He also serves as director of clinical chemistry postdoctoral training program at MD Anderson Cancer Center. He served as chair of the Canadian Academy of Clinical Biochemistry, chair of the Association for Diagnostics & Laboratory Medicine (formerly AACC) Nutrition Division, and chair of the American Association for Clinical Chemistry (AACC) Texas Section. Currently, he is chair of AACC Tumor Markers and Cancer Diagnostics, the Academy Council member and co-chair of IFCC Task Force on Global Lab Quality. His research interest focuses on tumor biology, tumor biomarkers, liquid biopsy, and cancer diagnostics. He is associate editor of Clinical Biochemistry and editor of Clinical Pathology section of Annals of Medicine. Dr. Meng has received several national research grants and a number of AACC and Canadian Society of Clinical Chemists awards including the research excellence award and outstanding service to the profession of clinical biochemistry.